Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Testing effectiveness (Phase 2)Looking for participantsNCT04803201What this trial is testingTesting the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaWho this might be right forAngioimmunoblastic T-cell LymphomaEnteropathy-Associated T-Cell LymphomaFollicular T-Cell Lymphoma+4 more Alliance for Clinical Trials in Oncology 170
Early research (Phase 1)Ended earlyNCT00671112What this trial is testingEverolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaWho this might be right for714leukemiaLymphoma Brian Hill, MD, PhD 30
Not applicableStudy completedNCT02652715What this trial is testingSalvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more Mayo Clinic 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06701344What this trial is testingGo-CHOP in de Novo Intestinal T-cell Lymphoma PatientsWho this might be right forEnteropathy Associated T Cell Lymphoma Ruijin Hospital 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03113500What this trial is testingBrentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell LymphomaWho this might be right forAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-Positive+8 more City of Hope Medical Center 48
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)WithdrawnNCT06692452What this trial is testingTazemetostat Plus CHOP in 1L T-cell LymphomaWho this might be right forLymphomaPeripheral T Cell LymphomaAngioimmunoblastic T-cell Lymphoma+2 more Eric Jacobsen, MD
Testing effectiveness (Phase 2)Study completedNCT02561273What this trial is testingCombination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's LymphomaWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveHepatosplenic T-Cell Lymphoma+7 more University of Nebraska 54
Not applicableStudy completedNCT02551289What this trial is testingMAgnetic Resonance Imaging in COeliac DiseaseWho this might be right forCeliac DiseaseCoeliac DiseaseCeliac Sprue+1 more University of Nottingham 72
Testing effectiveness (Phase 2)Study completedNCT00481871What this trial is testingStudy of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesWho this might be right forRelapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more Acrotech Biopharma Inc. 119
Testing effectiveness (Phase 2)Study completedNCT03217643What this trial is testingCHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.Who this might be right forEnteropathy Associated T-cell Lymphoma Imagine Institute 14
Not applicableStudy completedNCT00445952What this trial is testingNatural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 304
Early research (Phase 1)Study completedNCT00697346What this trial is testingStudy of MLN8237 in Participants With Advanced Hematological MalignanciesWho this might be right forB-cell Follicular LymphomaB-cell Marginal Zone LymphomaDiffuse Large B-cell Lymphoma+10 more Millennium Pharmaceuticals, Inc. 58
Testing effectiveness (Phase 2)UnknownNCT03638206What this trial is testingAutologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesWho this might be right forB-cell Acute Lymphoblastic LeukemiaLymphomaMyeloid Leukemia+13 more Shenzhen BinDeBio Ltd. 73
Testing effectiveness (Phase 2)UnknownNCT00669812What this trial is testingHigh-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell LymphomaWho this might be right forLymphomaSmall Intestine Cancer Cancer Research UK 60
Testing effectiveness (Phase 2)Looking for participantsNCT06580002What this trial is testingRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialWho this might be right forBreast CancerSarcomaGastric Cancer+19 more University of California, Irvine 75
Early research (Phase 1)UnknownNCT04480788What this trial is testingCD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label StudyWho this might be right forT Lymphoblastic Leukemia/LymphomaExtramedullary NK-T-cell Lymphoma, Nasal TypePeripheral T-cell Lymphoma, Nonspecific+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Post-approval studies (Phase 4)UnknownNCT01746992What this trial is testingCTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell LymphomaWho this might be right forALK-negative Anaplastic Large Cell LymphomaPeripherial T Cell Lymphoma,Not Otherwise SpecifiedAngioimmunoblastic T Cell Lymphoma+3 more Ruijin Hospital 200